Jan-Olof Andersson

Product Development Manager

Jan-Olof Andersson, born in 1954, has extensive experience working within the biotech and pharmaceutical industry, for example within AstraZeneca, Arexis and Biovitrum. Within Toleranzia Andersson is responsible for the protein-chemistry operations, including the development of both lab-scale and large-scale protein production processes for pre-clinical and clinical studies; the latter in collaboration with external companies, specializing in the production of protein pharmaceuticals.

Maria Fernandez

Programme Director

Maria Fernandez, born in 1987, has a PhD in medical science and an MSc in environmental science from the University of Gothenburg. Previous academic studies include a BSc in pharmaceutical chemistry. Her expertise focuses in immunology and inflammation. Fernandez has previously worked within the pharmaceutical industry in Eli Lilly.